Search Results - "labelling"

Can a 'rewards-for-exercise app' increase physical activity, subjective well-being and sleep quality? An open-label single-arm trial among university staff with low to moderate physical activity levels by Sakari Lemola, Anna Gkiouleka, Brieze Read, Anu Realo, Lukasz Walasek, Nicole K. Y. Tang, Mark T. Elliott

Connect to this object online.

Synthesis and Preclinical Evaluation of Novel ⁶⁸Ga-Labeled (<i>R</i>)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging by Shreya Bendre, Hsiou-Ting Kuo, Helen Merkens, Zhengxing Zhang, Antonio A. W. L. Wong, François Bénard, Kuo-Shyan Lin

Connect to this object online.

Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia by Ekaterina I. Alexeeva, Leyla S. Namazova-Baranova, Tatyana M. Bzarova, Saniya I. Valieva, Rina V. Denisova, Tatyana V. Sleptsova, Kseniya B. Isaeva, Alexandra M. Chomahidze, Nikolay I. Taibulatov, Anna N. Fetisova, Anna V. Karaseva, Alexandr A. Baranov

Connect to this object online.

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial by Olivier Godeaux, Martina Kovac, Daniel Shu, Katrijn Grupping, Laura Campora, Martine Douha, Thomas C. Heineman, Himal Lal

Connect to this object online.

Application of ^99mTc-Labeled WL12 Peptides as a Tumor PD-L1-Targeted SPECT Imaging Agent: Kit Formulation, Preclinical Evaluation, and Study on the Influence of Coligands by Mingxuan Fan, Jingjing Yao, Zuoquan Zhao, Xianzhong Zhang, Jie Lu

Connect to this object online.

Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study by Choi Y, Lee S, Cho SM, Kang WH, Nam KY, Jang IJ, Yu KS

Connect to this object online.

Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) by Alice T.W. Song, Vanderson Rocha, Alfredo Mendrone-Júnior, Rodrigo T. Calado, Gil C. De Santis, Bruno D. Benites, Carolina Costa-Lima, Taiani Vargas, Leonardo S. Marques, Juliana C. Fernandes, Felipe C. Breda, Silvano Wendel, Roberta Fachini, Luiz V. Rizzo, José Mauro Kutner, Vivian I. Avelino-Silva, Rafael R.G. Machado, Edison L. Durigon, Sylvie Chevret, Esper G. Kallas

Connect to this object online.

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study by Han SH, Oh GC, Kwon HM, Park CG, Kim IJ, Hwang GS, Yoo BS, Park SH, Lee KJ, Kim HS

Connect to this object online.

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study by Asmik Asatryan, Nadia Meyer, Michael Scherbakov, Victor Romanenko, Irina Osipova, Anna Galustyan, Olga Shamsheva, Tatiana Latysheva, Tatyana Myasnikova, Nathalie Baudson, Monique Dodet, Stebin Xavier, Lauriane Harrington, Anastasia Kuznetsova, Laura Campora, Peter Van den Steen

Connect to this object online.

"You can't just eat 16 teaspoons of sugar so why would you drink 16 teaspoons' worth of sugar?": a qualitative study of young adults' reactions to sugary drink warning labels by C Miller, K Wright, J Dono, S Pettigrew, M Wakefield, J Coveney, G Wittert, D Roder, S Durkin, J Martin, K Ettridge

Connect to this object online.

Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study by Mary Kaye Willian, Geert D'Haens, Aaron Yarlas, Ashish V. Joshi

Connect to this object online.

Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trialResearch in context by Ming-Ci Cai, Shu Cheng, Hong-Mei Jing, Yan Liu, Guo-Hui Cui, Ting Niu, Jian-Zhen Shen, Liang Huang, Xin Wang, Yao-Hui Huang, Li Wang, Peng-Peng Xu, Wei-Li Zhao

Connect to this object online.

A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial by William M. Hague, Leonie Callaway, Jennifer Chambers, Lucy Chappell, Suzette Coat, Jiska de Haan-Jebbink, Marloes Dekker, Peter Dixon, Jodie Dodd, Maria Fuller, Sanne Gordijn, Dorothy Graham, Oskari Heikinheimo, Annemarie Hennessy, Risto Kaaja, Teck Yee Khong, Laura Lampio, Jennie Louise, Angela Makris, Corey Markus, Hanns-Ulrich Marschall, Philippa Middleton, Ben W. Mol, Jonathan Morris, John P. Newnham, Caroline Ovadia, Michael Peek, Antonia Shand, Michael Stark, Jim Thornton, Susanna Timonen, Susan Walker, David Warrilow, Catherine Williamson

Connect to this object online.

Evaluation of the Effect of Patient Education and Strengthening Exercise Therapy Using a Mobile Messaging App on Work Productivity in Japanese Patients With Chronic Low Back Pain: Open-Label, Randomized, Parallel-Group Trial by Naohiro Itoh, Hirokazu Mishima, Yuki Yoshida, Manami Yoshida, Hiroyuki Oka, Ko Matsudaira

Connect to this object online.

Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid® (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study by Sneha A. Dongre, Gauri A. Kulkarni, Akshay Mishra, Rutuja B. Deshmane, Nameeta Sonar, Kanica Yashi, Damodar Thapa, Nikhil Ghade, Sachin M. Kadoo, Archana R. Krishnan, Sanjay M. Sonar

Connect to this object online.

Adherence with ethinylestradiol 20 &micro;g/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study by Wiegratz I, Elliesen J, Paoletti AM, Walzer A, Kirsch B

Connect to this object online.

Topical ruxolitinib 1.5% (JAK1/JAK2 inhibitor) improves clinical and patient‐reported outcomes in moderate to severe chronic hand dermatitis: Data from a small open‐label trial by Hannah D. Smith, Jag S. Lally, Alison Moy, Julie Ryan‐Wolf, Anna De Benedetto

Connect to this object online.

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer by Herlinde Dierick, Laurent Navarro, Hannelore Ceuppens, Thomas Ertveldt, Ana Rita Pombo Antunes, Marleen Keyaerts, Nick Devoogdt, Karine Breckpot, Matthias D'Huyvetter, Tony Lahoutte, Vicky Caveliers, Jessica Bridoux

Connect to this object online.

Comparative evaluation of clinical glycemic control markers treated with imeglimin and its effect on erythrocytes in patients with type 2 diabetes mellitus: study protocol of a single-arm, open-label, prospective, exploratory trial by Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Satako Douguchi, Kensuke Ofuchi, Makoto Katoh

Connect to this object online.

A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone® 3.75 mg in healthy male subjects by Xingjiang Hu, Qiao Zhang, Yunliang Zheng, You Zhai, Nana Xu, Qingwei Zhao, Jian Liu, Longyan Wan, Jindan Luo

Connect to this object online.